Rapamycin: How It Works and Why I’m Taking It for Life Extension
- © Nils Osmar 2025. October 25, 2025
- This post is not intended as, and should not be taken as, medical advice.
- See full Medical Disclaimer
In this article, I’ll be talking about a drug called rapamycin, which is used in high doses to prevent rejection in organ transplant cases – but in low doses, has become one of the most popular compounds used in the anti-aging community.
Rapamycin was originally discovered in soil samples from Easter Island in the 1970s. Researchers originally identified it as an antifungal compound, but they later found that it had powerful immune-suppressing effects, when used in large doses.
Rapamycin works by targeting a metabolic process called mTOR, and somewhat dampening the activation of mTOR in our bodies. mTOR exists in two forms, called complex 1 and complex 2. Rapamycin mostly affects the first one, mTORC1, which manages growth and cell building. It’s also a powerful activator of AMPK, the so-called anti-aging metabolic pathway.
When nutrients are plentiful, mTOR complex 1 tells cells: “Grow, divide, and build.” mTOR isn’t bad, from an anti-aging point of view; it’s associated with strong muscles, and a strong immune system. But if it’s “on” all the time, the effect may be speeding up, rather than slowing down, aging and age-related diseases.
Rapamycin doesn’t turn off mTORC1 completely, but it dials down its activation. Imagine mTOR for a moment as a fire that we need for warmth; rapamycin does not put it out, but keeps it from roaring out of control. It moves our cells and tissues out of a constant growth mode into a “maintenance and repair mode”, stimulating autophagy – recycling damaged components, reducing stress, and potentially slowing down aging.
In animal studies, rapamycin is one of the most reliable lifespan-extending compounds.The ITP, the National Institute on Aging’s Interventions Testing Program, has found that it consistently extends both median and maximum lifespan in mice, something that has been confirmed in multiple studies. Flies and and worms given rapamycin have also been shown to live longer, and have stronger immune responses as they age — even when the treatment is started very late in life, and for a limited period of time.
In humans, small clinical studies suggest that rapamycin, taken in small doses once a week or so, may improve immune function in older adults and reduce some markers of aging. We don’t know yet if taking it will increase the human lifespan, because people live too long to test its effects on lifespan easily. It would take us more than a human lifespan to be absolutely sure that any intervention is increasing our years on Earth.
Rapamycin isn’t risk-free. In transplant patients taking high doses, it can increase infection risk, raise blood sugar, and cause mouth ulcers.
Recent studies have clarified that generic rapamycin is more effective than compounded rapamycin, per milligram. I’m currently taking 4 to 6 mg of generic rapamycin once a week, 9 months out of the year. I take it on Sundays, on a day when I also do fasting.
Not medical adviceThis article is not intended as, and should not be taken as, medical advice. I’m not advising that people eat any particular diet or take any particular supplement(s), just reporting on what I’m doing. Supplements, like medications and other interventions, can have side effects; I would encourage people to research both possible benefits and side effects before starting on any supplementation regimen, and consult with a medical professional about any issues which might have a medical component. See full Medical Disclaimer
Is My Article Accurate? Let’s Find Out!
After writing the above article, I asked Claude.AI to read it critically and assess the claims that I made in it, correcting anything that I might have misstated.
In my experience, AIs excel at jobs like this, moreso than at creating new articles. If they create a brand new articles based on their own research, they will often, due to a pressure to come up with answers, hallucinate where accurate information is not available; but when they’re assessing articles which have already been written, they turn on their logic capabilities and can look critically at each point and verify it’s accuracy,
Here is what Claude said:
Accuracy Assessment of Your Article – by Claude.ai
Overall, your article is well-written and accurate. Here are my findings:
What’s spot-on:
- ✅ Discovery on Easter Island in the 1970s
- ✅ Originally identified as antifungal
- ✅ mTOR targeting and the two complexes (mTORC1 and mTORC2)
- ✅ Rapamycin primarily affects mTORC1
- ✅ Autophagy stimulation
- ✅ ITP findings and animal studies
- ✅ Late-life benefits in animal studies
- ✅ Small human studies showing immune function improvements
- ✅ Side effects in transplant patients
- ✅ Generic vs compounded effectiveness – this is accurate and based on very recent 2024 research!
Minor issues to correct:
- “It’s also a powerful activator of AMPK” – This statement is misleading. Rapamycin primarily works by inhibiting mTOR, not by activating AMPK. While there’s some evidence that rapamycin can lead to AMPK activation in certain contexts (particularly at high doses), this is a secondary or indirect effect, not its primary mechanism. I’d suggest either removing this sentence or revising it to something like: “By inhibiting mTOR, rapamycin helps shift cellular metabolism toward maintenance and repair.”
- “brapamycin” in one sentence appears to be a typo – should be “rapamycin” (Note: I corrected this typo. – Nils)
Those are the only issues I found. Your dosing information and personal protocol are within the range being explored in the longevity community.
Companion Article: The Evidence For and Against Rapamycin for Healthy Aging
By Claude (Anthropic)
If you’re reading about rapamycin for life extension, you’ve probably heard enthusiastic claims about this “longevity drug.” But you’ve also likely encountered warnings about potential risks. So what does the science actually tell us? Let me walk you through what we know—and what we don’t.
The Case For: Why Some People Are Taking Rapamycin
The animal evidence is genuinely impressive. Rapamycin stands out as one of the most reliably life-extending compounds ever tested in laboratory animals. The National Institute on Aging’s Interventions Testing Program has shown that it consistently extends both average and maximum lifespan in mice—and importantly, these benefits appear even when the treatment starts late in life. We’re talking about animals living 10-20% longer, with improvements in health markers along the way.
Recent human trials are showing promise. The PEARL trial, published in 2024-2025, was the first long-term human study of rapamycin for healthy aging. After 48 weeks of treatment, researchers found that a 10mg weekly dose helped preserve lean muscle mass in women and bone mineral content in men—both markers that typically decline with age. No serious side effects were reported in this healthy population.
Other small studies have suggested that rapamycin (or its close relative everolimus) might improve immune function in older adults, potentially helping them respond better to vaccines. There’s also ongoing research looking at whether it might help with gum disease, which tends to worsen with age and is linked to other health problems.
The mechanism makes biological sense. By dampening the mTOR pathway—which controls cell growth and metabolism—rapamycin mimics some of the beneficial effects we see with calorie restriction. It promotes autophagy (the cellular “cleanup” process), reduces inflammation, and may help cells focus on repair rather than constant growth. At least in theory, this could slow multiple aspects of aging simultaneously.
The Case Against: Real Concerns Worth Considering
We don’t actually know if it extends human lifespan. This is the elephant in the room. Yes, rapamycin works beautifully in mice, but mice aren’t people. Humans live too long to test lifespan extension easily, and many interventions that worked in animals have failed in humans. We won’t know for certain whether rapamycin extends human life for many decades—if ever.
Note from Nils: Claude is right about this. On the other hand, some of us don’t have decades to wait before trying anti-aging interventions.
The side effects at high doses are well-documented. When used at immunosuppressive doses (as in transplant patients), rapamycin can cause mouth sores, increase infection risk, raise blood sugar and cholesterol levels, impair wound healing, and in some cases affect fertility. While the low doses being explored for longevity (typically 3-10mg weekly) appear to cause fewer side effects, they’re not risk-free. Tech entrepreneur Bryan Johnson, who publicly experimented with rapamycin, discontinued it in 2025 citing elevated blood glucose, susceptibility to infections, and impaired healing.
Note from Nils: I don’t really agree with Claude on this point. For a counter argument, see Matt Kaerberlein’s take on Bryan Johnson’s approach lower on this page.
We lack validated endpoints and long-term safety data. Most human studies so far have been short-term (weeks to months) and have looked at indirect markers like immune response to vaccines or muscle mass changes. We don’t have comprehensive data on what happens when healthy people take rapamycin for years or decades. Some recent research has raised concerns about whether enhancing autophagy might inadvertently support existing tumors, even if it helps prevent new ones from forming.
Note from Nils: this is one of the points in which I agree with Claude. There are cases in which autophagy can have negative effects. This is one of the reasons that I would always recommend that people tell their doctors they’re taking rapamycin.
The dosing is complicated and highly individual. Recent studies on bioavailability have revealed significant variation in how different people absorb and respond to rapamycin. Blood levels can vary dramatically between individuals taking the same dose, which means finding the right amount is tricky without regular monitoring—something most people using it off-label aren’t doing.
It might work differently in men and women. The PEARL trial suggested that the benefits might be sex-specific (muscle preservation in women, bone preservation in men at the same dose). We don’t yet understand these differences well enough to optimize treatment.
The Middle Ground: What Scientists Actually Think
Most longevity researchers I’ve reviewed land somewhere in the middle. They’re excited about rapamycin’s potential but cautious about widespread use outside of clinical trials. Here’s the consensus emerging from the scientific literature:
- Rapamycin is a legitimate research priority. It deserves serious study in humans, and several clinical trials are underway.
- The risks and benefits likely depend heavily on dose and schedule. Low, intermittent dosing (like once weekly) appears to minimize side effects while potentially preserving benefits, but optimal protocols are still being worked out.
- Monitoring is essential. Anyone taking rapamycin should be working with a physician who can check blood levels and watch for side effects like elevated glucose, cholesterol changes, or immune suppression.
- Context matters. The risk-benefit calculation might be different for someone who’s 70 versus someone who’s 40, or for someone with a family history of cancer versus someone without.
Note from Nils: I agree with Claude that monitoring is essential. I buy my rapamycin through AgelessRX.com. It’s a little pricey, but it includes regular blood tests which are monitored by their doctors to make sure that there are no negative effects.
The Bottom Line
Rapamycin represents one of our most promising leads in the quest to slow human aging. The animal data is compelling, early human studies are encouraging, and the biological rationale is sound. But we’re essentially in the “promising but unproven” stage—like being in the early trials of a new medication.
Taking rapamycin for healthy aging right now is, in a very real sense, a personal experiment. Some people—after weighing the known risks against potential benefits and working with informed physicians—are choosing to proceed. Others are waiting for more definitive human data. Both positions are reasonable given our current state of knowledge.
If you’re considering rapamycin, the most important thing is to make an informed choice: understand both the genuine promise and the real uncertainties, work with a physician who can monitor you properly, and recognize that you’re participating in what is effectively an ongoing scientific experiment—one where the results won’t be fully known for decades to come.
This article was written by Claude (Anthropic) at the request of Nils Osmar to provide balanced context for readers interested in the current state of rapamycin research for healthy aging.
Matt Kaeberlein on Bryan Johnson’s statements against Rapamicyn — and why they don’t make sense, from Matt’s point of view
Other resources
- My Youtube channel Pathways to Longevity
- My Facebook group: Anti-Aging and Life Extension,
